Billed as nonaddictive, new pain pill could soon win FDA approval
A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...
New York Post27d
FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
The the US Food and Drug Administration (FDA) has approved the first medication to ... The agency said that along with the drug, a reduced-calorie diet and increased physical activity should ...
Medical Xpress24d
FDA approves Tryngolza as adjunct to diet for familial chylomicronemia syndrome
Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce triglycerides ... via an autoinjector. The FDA approval was based on data from ...
Fox News28d
FDA approves first medication for obstructive sleep apnea, which also promotes weight loss
On Dec. 20, the FDA announced that the agency has approved Eli Lilly's ... in adults with obesity. The drug is to be paired with a reduced-calorie diet and increased physical activity, the FDA ...
Onlymyhealth22d
FDA Approves Weight-Loss Drug Zepbound For Obstructive Sleep Apnea
The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound ... The drug is designed to be used alongside a reduced-calorie diet and increased physical activity, offering ...
Zawya9d
FDA approves Tirzepatideas: The first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity
Averaging up to 20% of weight loss, adults taking Tirzepatide had at least 25 fewer breathing interruptions each hour as they ...
San Diego Union-Tribune21d
FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration approved Eli Lilly ... which help people shave pounds. The FDA first approved Zepbound to treat obesity in November 2023. Its active ingredient, tirzepatide ...
Hosted on MSN25d
FDA Approves Tryngolza as Adjunct to Diet for Familial Chylomicronemia Syndrome
FRIDAY, Dec. 27, 2024 (HealthDay News) -- Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce ... The FDA approval was based on data ...
Staten Island Advance20d
FDA approves first-ever medication for obstructive sleep apnea
The Food and Drug Administration (FDA) gave the green light ... in combination with a reduced-calorie diet and increased physical activity. “Today’s approval marks the first drug treatment ...
The Washington Post9d
Billed as nonaddictive, new pain pill could soon win FDA approval
The long quest for powerful non-opioid drugs that treat pain without risk of addiction is nearing a milestone, in the form of a pill that could soon win approval from the Food and Drug Administration.
Pharmabiz29d
US FDA approves Ionis Pharma’s Tryngolza to treat adults living with familial chylomicronemia syndrome as an adjunct to diet
Ionis Pharmaceuticals, Inc, a biotechnology company that develops RNA-targeted therapeutics, announced that the US Food and Drug Administration (FDA) has approved Tryngolza (olezarsen) as an adjunct ...